导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 13.49% | 683/4773 |
| 近一周 | 0.29% | 660/5465 |
| 近一月 | -6.05% | 4018/5421 |
| 近一季 | -10.52% | 3767/5231 |
| 近半年 | 13.14% | 428/4920 |
| 近一年 | 17.97% | 663/4394 |
| 近两年 | 167.76% | 164/2954 |
| 近三年 | 124.30% | 73/2253 |
| 成立以来 | 139.96% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.97% 3985/4961 |
52.17% 547/5312 |
- - |
- - |
| 2025 | 65.51% 146/4813 |
5.12% 825/3635 |
1.52% 2295/4076 |
55.10% 190/4524 |
-0.01% 2300/4813 |
| 2024 | 20.75% 443/3463 |
-1.18% 1194/2808 |
-2.59% 1210/3014 |
14.38% 1982/3129 |
9.68% 314/3463 |
| 2023 | 11.07% 78/2656 |
36.27% 51/2280 |
-2.92% 714/2385 |
-13.29% 2145/2515 |
-3.16% 618/2655 |
| 2022 | -32.69% 1682/2207 |
-19.47% 1462/1919 |
-2.62% 1783/2016 |
-19.55% 1786/2113 |
6.69% 349/2208 |
| 2021 | 10.63% 424/1822 |
-5.39% 921/1255 |
13.89% 274/1330 |
-7.57% 1062/1466 |
11.08% 94/1822 |
| 2020 | 26.75% 594/1250 |
5.42% 54/1028 |
19.77% 291/1067 |
1.03% 1033/1164 |
-0.63% 1081/1184 |
| 2019 | 59.15% 57/1092 |
42.72% 36/754 |
-8.29% 592/804 |
14.08% 20/850 |
6.59% 587/918 |
| 2018 | -30.49% 469/834 |
- - |
- - |
- - |
-13.55% 540/691 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 融通人工智能指数(LOF)A VS. 长安沪深300非周期A(740101) |